Autoimmune hepatitis: Difference between revisions

Line 32: Line 32:
*[[Non-alcoholic steatohepatitis]]
*[[Non-alcoholic steatohepatitis]]
*Cardiac cirrhosis
*Cardiac cirrhosis
*Primary biliary cirrhosis, [[primary sclerosing cholangitis]]
*Primary biliary cirrhosis
*[[primary sclerosing cholangitis]]
*[[Budd-Chiari]]
*[[Budd-Chiari]]
*Alpha1 anti-trypsin Deficiency
*Alpha1 anti-trypsin Deficiency
*[[Cystic Fibrosis]]
*[[Cystic Fibrosis]]
*[[Wilson's disease]]
*[[Sarcoidosis]]


==Evaluation==
==Evaluation==

Revision as of 07:03, 18 August 2022

Background

  • Hepatocellular inflammation caused by autoimmune pathology, ultimately leading to necrosis and cirrhosis
  • Presentation may be acute or chronic, rarely presents as fulminant hepatic failure
  • Usually affects women (~70%[1] between age 15-40 years
  • Often occurs comorbidly with other autoimmune disorders (e.g. type 1 diabetes, thyroid disease, inflammatory bowel disease, Sjögren's)
  • 3 subtypes of autoimmune hepatitis: types 1-3, with type 1 being the most common

Clinical Features

Findings of liver disease and systemic signs/symptoms of autoimmune disorders

Differential Diagnosis

Evaluation

Management

Disposition

See Also

External Links

References